Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05849844

Tympanoseal Clinical Study

The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.

Recruiting

Interested in participating?

Request Info

Key information

Age range

2 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Michigan Ear Institute, Farmington Hills, Michigan, United States

Loading trial locations.

About this study

This study will provide data on the safety and the ability of sodium/calcium alginate gels to act as a scaffold capable of occluding a tympanic membrane perforation over the duration of complete healing. Tympanoseal could be used in cases where cartilage or fat graft tympanoplasty would be indicated.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patients over 2 years of age at enrollment
  • Documentation of a retained tympanostomy tube or perforation less than 5 mm not on the edge of the tympanic membrane.
  • Written informed consent (and assent when applicable) obtained from subject or subject's legal guardian and ability for subject to comply with the requirements of the study

Exclusion criteria

  • Active otorrhea or otitis media
  • Otorrhea or otitis media within 4 weeks prior to the operation
  • History of cholesteatoma
  • Perforations on the edge of the tympanic membrane
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
  • Subject is taking systemic/oral corticosteroids
  • Subject will require the continued use of any type of topical otic medication to the ear(s) with Tympanoseal

Treatment and study plan

Tympanoseal

Device

All subjects will receive the Tympanoseal device that will be placed during a surgical procedure

Primary outcomes

  1. Number of participants with healed tympanic membrane perforations.

    Time frame: 12 weeks

    The purpose of this investigational study is to assess the safety of Tympanoseal when used during the healing process. Subject will be observed during the study and the the healing process of the tympanic membrane. Information will be gathered via report forms during regular visits of the patient to the investigator.

Secondary outcomes

  1. Number of participants with treatment-related adverse events

    Time frame: 12 weeks

    Determine if any adverse events occur during presence of material on tympanic membrane.

Study contacts

Contact information is provided by the study sponsor or research team.

Robert Stroup

CONTACT

[email protected]

901-386-0990

Sponsors and collaborators

Lead sponsor

Grace Medical, Inc.

Industry

Registry information

Official study title

Tympanoseal (Tympanic Membrane Device) Clinical Study

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
May 9, 2023
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.